Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

Regulatory T cells, which calm overactive immune responses, could play a role in autoimmune conditions, HIV cure research and cancer immunotherapy.

“Although lobular breast cancer accounts for a little over 10% of all breast cancers, the sheer number of new diagnoses each year makes this disease important to understand,” said Angela Giaquinto, ...

To amass the data for the investigation, Pro Publica, a nonprofit newsroom specializing in investigative journalism, utilized software and modeling tools developed by the Environmental Protection ...

With less than a month to go before many Americans pick their health insurance plans for the next year, Democrats in Congress are holding up government funding to pressure Republicans into extending ...

Health center leaders are building a coalition that “hopefully” will include the main stakeholders in the county’s health care system — community health centers, clinics, hospitals, doctors, health ...

Immunotherapy is a new and exciting way to treat cancer. Instead of using strong medicines that attack both healthy cells and cancer cells, immunotherapy helps the body’s own immune system find and ...

Lymphoma occurs when white blood cells of the immune system grow out of control. It can involve B cells, T cells or natural killer cells—three kinds of lymphocytes. There are two main types, Hodgkin ...

Dr. Mark Farrugia of Roswell Park Comprehensive Cancer Center describes new approach to post-operative radiation therapy for NSCLC.

“There is no easy way to say this but I know my wife @camilla_row would have wanted me to thank every person from all over the world who prayed for her over the last 8 years she suffered immeasurably ...

American Cancer Society researchers stress the need to increase access to cancer care for historically marginalized populations to help mitigate disparities.

Dry-One-8770, a 26-year-old based in California who asked to be called Alex, developed long COVID after an infection in March 2022. He tried low-dose naltrexone and every supplement he could get his ...